140 related articles for article (PubMed ID: 8502664)
1. Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats.
Chao J; Simson JA; Chung P; Chen LM; Chao L
Proc Soc Exp Biol Med; 1993 Jun; 203(2):243-50. PubMed ID: 8502664
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats.
Arcot SS; Fagerland JA; Lipke DW; Gillespie MN; Olson JW
Growth Factors; 1995; 12(2):121-30. PubMed ID: 8679246
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo.
Chen LM; Chung P; Chao S; Chao L; Chao J
Biochim Biophys Acta; 1992 Jun; 1131(2):145-51. PubMed ID: 1610894
[TBL] [Abstract][Full Text] [Related]
5. Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline-induced pulmonary hypertension.
Iwasaki T; Takahashi T; Shimizu H; Ohmori E; Morimoto T; Kajiya M; Takeuchi M; Morita K; Akagi R; Kajiya F
Curr Neurovasc Res; 2005 Apr; 2(2):133-9. PubMed ID: 16181105
[TBL] [Abstract][Full Text] [Related]
6. Salusin-β contributes to vascular inflammation associated with pulmonary arterial hypertension in rats.
Xu T; Zhang Z; Liu T; Zhang W; Liu J; Wang W; Wang J
J Thorac Cardiovasc Surg; 2016 Oct; 152(4):1177-87. PubMed ID: 27353339
[TBL] [Abstract][Full Text] [Related]
7. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats.
Wang C; Chao C; Chen LM; Chao L; Chao J
Am J Physiol; 1996 Oct; 271(4 Pt 2):F824-30. PubMed ID: 8898012
[TBL] [Abstract][Full Text] [Related]
8. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
Kodavanti UP; Jackson MC; Ledbetter AD; Richards JR; Gardner SY; Watkinson WP; Campen MJ; Costa DL
J Toxicol Environ Health A; 1999 Aug; 57(8):543-63. PubMed ID: 10515573
[TBL] [Abstract][Full Text] [Related]
9. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
Partovian C; Adnot S; Eddahibi S; Teiger E; Levame M; Dreyfus P; Raffestin B; Frelin C
Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Nakazawa H; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
Vignozzi L; Morelli A; Cellai I; Filippi S; Comeglio P; Sarchielli E; Maneschi E; Vannelli GB; Adorini L; Maggi M
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):277-292. PubMed ID: 27425465
[TBL] [Abstract][Full Text] [Related]
13. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
14. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
[TBL] [Abstract][Full Text] [Related]
15. Hemin treatment abrogates monocrotaline-induced pulmonary hypertension.
Shimzu K; Takahashi T; Iwasaki T; Shimizu H; Inoue K; Morimatsu H; Omori E; Matsumi M; Akagi R; Morita K
Med Chem; 2008 Nov; 4(6):572-6. PubMed ID: 18991742
[TBL] [Abstract][Full Text] [Related]
16. Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung.
Lee YS; Byun J; Kim JA; Lee JS; Kim KL; Suh YL; Kim JM; Jang HS; Lee JY; Shin IS; Suh W; Jeon ES; Kim DK
Exp Mol Med; 2005 Feb; 37(1):27-35. PubMed ID: 15761249
[TBL] [Abstract][Full Text] [Related]
17. Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats.
Lipke DW; Arcot SS; Gillespie MN; Olson JW
Am J Respir Cell Mol Biol; 1993 Oct; 9(4):418-28. PubMed ID: 8398180
[TBL] [Abstract][Full Text] [Related]
18. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
19. Tissue distribution and kininogen gene expression after acute-phase inflammation.
Chao J; Swain C; Chao S; Xiong W; Chao L
Biochim Biophys Acta; 1988 Mar; 964(3):329-39. PubMed ID: 3126819
[TBL] [Abstract][Full Text] [Related]
20. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]